Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jens Guenter Lohr, Ph.D., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Jens Lohr and Jacob Laubach.
Jens Lohr
Connection Strength
0.915
Jacob Laubach
  1. Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma. Leukemia. 2022 Apr; 36(4):1078-1087.
    View in: PubMed
    Score: 0.245
  2. Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nat Cell Biol. 2021 11; 23(11):1199-1211.
    View in: PubMed
    Score: 0.241
  3. Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clin Cancer Res. 2021 12 01; 27(23):6432-6444.
    View in: PubMed
    Score: 0.240
  4. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing. Leukemia. 2018 08; 32(8):1838-1841.
    View in: PubMed
    Score: 0.188
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.